Time to revise your HIV testing routine

Journal of Family Practice

Volumn 56, Issue 4, 2007, Pages 283-284

  Campos Outcalt, Doug ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; DIAGNOSTIC TEST; FEMALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COUNSELING; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK REDUCTION; SHORT SURVEY;

ADULT; AIDS SERODIAGNOSIS; ATTITUDE TO HEALTH; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FAMILY PRACTICE; FEMALE; FORECASTING; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; TIME FACTORS; UNITED STATES;

EID: 34247496312     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Branson BM, Handsfield HH, Lampe MA, et al; CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Recomm Rep 2006; 55(RR-14):1-17. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed on March 16, 2007.
2. CDC. US HIV and AIDS cases reported through December 2001. HIV/AIDS Surveillance Report 2001; 13(2). Available at: www.cdc.gov/hiv/stats/ hasr1302. htm. Accessed on March 13, 2007.
3. Institute of Medicine. No Time to Lose: Getting More from HIV Prevention. Washington, DC: National Academy Press; 2001.
4. Peterman TA, Todd KA, Mupanduki I. Opportunities for targeting publicly funded human immunodeficiency virus counseling and testing. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:69-74.
5. CDC. HIV testing among pregnant women - US and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002; 51:1013-1016.
6. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999; 13: 1687-1695.
7. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
8. Irwin KL, Valdiserri RO, Holmberg SD. The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS 1996; 10:1707-1717.
9. Hutchinson AB, Corbie-Smith G, Thomas SB, et al. Understanding the patient's perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Educ Prev 2004; 16:101-114.
10. Spielberg F, Branson BM, Goldbaum GM, et al. Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. J Acquir Immune Defic Syndr 2003; 32:318-328.
11. Copenhaver MM, Fisher JD. Experts outline ways to decrease the decade-long yearly rate of 40,000 new HIV infections in the US. AIDS Behav 2006;10:105-114.
12. Weinhard LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a metanalytic review of published research 1985-1997. Am J Public Health 1999; 89:1397-1405.
13. USPSTF. Recommendation statement: Screening for HIV. Available at: www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical. Accessed on March 13, 2007.